GleamWall
中文EN

PLRZ Polyrizon Ltd. Annual reports only

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1893645 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY-115.9%
TTM EPS YoY-99.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-25.4%
ROA-24.7%
ROIC (approx.)-44.0%
Asset turnover—

Leverage & solvency

Liabilities / assets2.1%
Debt / equity0.00x
Current ratio29.03x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.36x
Accruals ratio8.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$2.13M$534,000
SG&A expense$4.12M$768,000
Operating income-$6.25M-$1.30M
Net income-$3.33M-$1.54M
EBITDA-$5.91M-$1.18M
EPS (basic)4.90805.20
EPS (diluted)4.90805.20
Weighted avg. shares (diluted)680,3801,994
Balance sheet
Cash & equivalents$1.31M$2.55M
Current assets$12.86M$2.65M
PP&E, net$12,000$10,000
Intangibles$2.55M$2.88M
Total assets$21.44M$5.55M
Current liabilities$443,000$261,000
Total liabilities$443,000$261,000
Shareholders' equity$20.99M$5.29M
Shares outstanding1.61M2,796
Cash flow statement
Operating cash flow-$4.53M-$1.15M
Capital expenditure$7,000—
Free cash flow-$4.54M—
Investing cash flow-$16.53M$29,000
Financing cash flow$19.81M$3.67M
Depreciation & amortization$342,000$118,000
Stock-based compensation$1.31M$51,000

Free plan shows the latest 2 periods; Pro shows all 4 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.